April 20, 2018 12:29 PM EDT
Deals

Press­ing for di­rect ne­go­ti­a­tions, Take­da adds cash to a meati­er $63B bid to buy Shire

John Carroll

Editor & Founder

Look­ing to whip up some en­thu­si­asm for its quest to buy out Shire, Take­da has sweet­ened its of­fer to £47 a share, adding £.5 with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Out­look's shares crash as wet AMD drug flunks Phase 3 test

A service from the Financial Times